The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Strategies for transporting nanoparticles across the blood–brain barrier
Abstract
Nanoparticles have been widely deployed for brain-targeted delivery. Drugs can be embedded either in a matrix or deposited on the surface of nanoparticles, and the whole particle can cross the BBB effectively and be targeted to specific parts of the body in a controllable manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Research works printed but not linked: 8
- Weidle, 2015, Cancer Genomics Proteomics, 12, 167
- Schmid-Brunclik, 2008, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 295, R864
- Hagg, 2006, J. Neurotrauma, 23, 264
- Kozler, 2012, Neuroendocrinol. Lett., 33, 782
- Piraux, 2015, J. Appl. Phys., 117
- Zheng, 2015, Int. J. Clin. Exp. Med., 8, 1658
- Nounou, 2014, Cancer Res., 74
- Maletinska, 2000, Cancer Res., 60, 2300
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“70,71 Moreover, for invertebrates that lack a vascularized circulatory system, astrocytes are the main components of the barrier separating humoral fl uids from the CNS. 72 Pericytes .”
BackgroundInfluentialCrossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
“such as non-invasiveness, low cost, good biodegradability and longterm stability, ease of synthesis, high targeting efficiency, and high controllability to load and release drugs across the BBB [40,41].”
BackgroundThe therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
“Compared to freely diffusing hydrophobic drugs, drug-loaded NPs have higher solubility, in vivo stability, increased specific bio- distribution and better control of drug release (Kim et al., 2009; Zhang et al., 2011).”
BackgroundSelf-citation
Metadata
- Authors
- Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W.
- Affiliations
- Department of Food Science and Technology
- IHRC
- Tongde Hospital of Zhejiang Province (CN)
- North Carolina Agricultural and Technical State University (US)
- South China University of Technology (CN)
- Corresponding author
- Liao, Wenzhen
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2016
- Volume
- 4
- Issue
- 2
- Pages
- 219-229
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W2190350005
- Cited by
- 308
- References
- 115
- Citations by year
- 2026: 6 · 2025: 35 · 2024: 40 · 2023: 31 · 2022: 33 · 2021: 33 · 2020: 41 · 2019: 21 · 2018: 23 · 2017: 24 · 2016: 21
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, nanoparticles, brain drug delivery, central nervous system disorders, nanomedicine
- MeSH terms
- Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System, Central Nervous System Diseases, Humans, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies for transporting nanoparticles across the blood–brain barrier. https://app.cochat.ai/papers/10.1039/c5bm00383k
- The paper
- Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016). Strategies for transporting nanoparticles across the blood–brain barrier. Biomaterials Science. https://doi.org/10.1039/c5bm00383k
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.